The advent of Covid-19 meant that regional Life Sciences business leaders have been forced to navigate a broad range of issues. These include employee and customer safety, shoring-up cash for liquidity, reorienting operations to ensure supplies, and navigating government support programs and regulatory changes.
In an effort to bring a degree of clarity to compliance issues emerging from the current environment, our inaugural compliance survey comprises interviews with Middle East based leaders from Life Sciences principals and large regional distributors.
Our inaugural Middle East Life Sciences compliance survey provides a view on related practices in the sector. The purpose of the survey was to highlight compliance risks and associated trends, as well as identify mitigation strategies for Life Sciences companies.